Efficacy of Rimegepant 75 mg for the Acute Treatment of Migraine: a Bayesian Individual Participant Data Meta-analysis Standardized to Defined Target Populations

​ Conditions: Migraine

Interventions: Drug: Rimegepant; Drug: Placebo

Sponsors: Pfizer

Active, not recruiting Conditions: Migraine
Interventions: Drug: Rimegepant; Drug: Placebo
Sponsors: Pfizer
Active, not recruiting